These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 24107322)
1. Utilization of p40 (ΔNp63) with p63 and cytokeratin 5/6 immunohistochemistry in non-small cell lung carcinoma fine-needle aspiration biopsy. Collins BT; Wang JF; Bernadt CT Acta Cytol; 2013; 57(6):619-24. PubMed ID: 24107322 [TBL] [Abstract][Full Text] [Related]
2. Endobronchial ultrasound fine-needle aspiration biopsy of pulmonary non-small cell carcinoma with subclassification by immunohistochemistry panel. Collins BT Cancer Cytopathol; 2013 Mar; 121(3):146-54. PubMed ID: 22927132 [TBL] [Abstract][Full Text] [Related]
3. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Mukhopadhyay S; Katzenstein AL Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283 [TBL] [Abstract][Full Text] [Related]
4. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis. Vogt AP; Cohen C; Siddiqui MT Diagn Cytopathol; 2014 May; 42(5):453-8. PubMed ID: 24166777 [TBL] [Abstract][Full Text] [Related]
5. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung. Argon A; Nart D; Veral A Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962 [TBL] [Abstract][Full Text] [Related]
7. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases. Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515 [TBL] [Abstract][Full Text] [Related]
8. p40 (ΔNp63) and keratin 34βE12 provide greater diagnostic accuracy than p63 in the evaluation of small cell lung carcinoma in small biopsy samples. Butnor KJ; Burchette JL Hum Pathol; 2013 Aug; 44(8):1479-86. PubMed ID: 23528865 [TBL] [Abstract][Full Text] [Related]
9. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens. Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169 [TBL] [Abstract][Full Text] [Related]
10. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers. Koh J; Go H; Kim MY; Jeon YK; Chung JH; Chung DH Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792 [TBL] [Abstract][Full Text] [Related]
12. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung. Brown AF; Sirohi D; Fukuoka J; Cagle PT; Policarpio-Nicolas M; Tacha D; Jagirdar J Arch Pathol Lab Med; 2013 Sep; 137(9):1274-81. PubMed ID: 23289761 [TBL] [Abstract][Full Text] [Related]
13. A study of ΔNp63 expression in lung non-small cell carcinomas. Nonaka D Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298 [TBL] [Abstract][Full Text] [Related]
14. ΔNp63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens. Zhao W; Wang H; Peng Y; Tian B; Peng L; Zhang DC Int J Clin Exp Pathol; 2014; 7(7):4247-53. PubMed ID: 25120805 [TBL] [Abstract][Full Text] [Related]
15. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma. Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895 [TBL] [Abstract][Full Text] [Related]
16. Head-to-Head Comparison of p63 and p40 in Non-Neuroendocrine Carcinomas of the Tubal Gut. Bakhshwin AM; Gordon IO; Brown KB; Liu X; Allende DS Int J Surg Pathol; 2020 Dec; 28(8):835-843. PubMed ID: 32466705 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors. Zhang C; Schmidt LA; Hatanaka K; Thomas D; Lagstein A; Myers JL Am J Clin Pathol; 2014 Sep; 142(3):320-4. PubMed ID: 25125621 [TBL] [Abstract][Full Text] [Related]
18. Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer. Kriegsmann K; Cremer M; Zgorzelski C; Harms A; Muley T; Winter H; Kazdal D; Warth A; Kriegsmann M Pathology; 2019 Apr; 51(3):240-245. PubMed ID: 30798982 [TBL] [Abstract][Full Text] [Related]
19. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas. Noh S; Shim H Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426 [TBL] [Abstract][Full Text] [Related]
20. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique. Kawai T; Tominaga S; Hiroi S; Kameda K; Ogata S; Nakashima H; Ozeki Y; Nakanishi K Acta Cytol; 2015; 59(6):457-64. PubMed ID: 26696549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]